Prelude Capital Management’s Mesa Laboratories MLAB Stock Holding History

Prelude Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-34	Closed	-$8K	–	1962
2019 Q1	$8K	Buy	+34	New	+$7.68K	﹤0.01%	1528
2015 Q1	–	Sell	-286	Closed	-$22K	–	2067
2014 Q4	$22K	Buy	+286	New	+$20.9K	﹤0.01%	1716
2014 Q3	–	Sell	-400	Closed	-$34K	–	2022
2014 Q2	$34K	Hold	400	–	–	﹤0.01%	1599
2014 Q1	$36K	Buy	+400	New	+$34K	﹤0.01%	1451

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Prelude Capital Management's MLAB Position: Q2 2019 in Review

Prelude Capital Management sold out of Mesa Laboratories (MLAB) in Q2 2019, closing a stake of 34 shares — an estimated $8K sold.

Prelude Capital Management first reported a position in MLAB in Q1 2014 and held it in 4 quarters. The position peaked at $36K in Q1 2014. 125 funds tracked by Wall St. Rank hold MLAB as of Q2 2019.

Prelude Capital Management reported no remaining Mesa Laboratories position as of Q2 2019 after selling out during the quarter.
Prelude Capital Management sold 34 Mesa Laboratories shares in Q2 2019, an estimated $8K.
Prelude Capital Management first reported a position in Mesa Laboratories in Q1 2014 and held it in 4 quarters.
Prelude Capital Management's Mesa Laboratories position peaked at $36K in Q1 2014.
125 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.